Erik W Bloomquist - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Erik W Bloomquist

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2021

Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case ExamplesAnup K Amatya, Mallorie H Fiero, Erik W Bloomquist, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2021

U.S. FDA Drug Approvals for Breast Cancer: A Decade in ReviewShaily Arora, Preeti Narayan, Christy L Osgood, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2021

U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in ReviewShaily Arora, Preeti Narayan, Gwynn Ison, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2022

FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated TumorsJaleh Fallah, Michael H Brave, Chana Weinstock, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2020

FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast CancerJennifer J Gao, Christy L Osgood, Yutao Gong, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2021

Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case ExamplesAnup K Amatya, Mallorie H Fiero, Erik W Bloomquist, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2021

U.S. FDA Drug Approvals for Breast Cancer: A Decade in ReviewShaily Arora, Preeti Narayan, Christy L Osgood, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2021

U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in ReviewShaily Arora, Preeti Narayan, Gwynn Ison, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2022

FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated TumorsJaleh Fallah, Michael H Brave, Chana Weinstock, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2020

FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast CancerJennifer J Gao, Christy L Osgood, Yutao Gong, et al.

Pageof 2